174 related articles for article (PubMed ID: 10329150)
1. Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping.
Yang F; Bewley CA; Louis JM; Gustafson KR; Boyd MR; Gronenborn AM; Clore GM; Wlodawer A
J Mol Biol; 1999 May; 288(3):403-12. PubMed ID: 10329150
[TBL] [Abstract][Full Text] [Related]
2. Domain-swapped structure of a mutant of cyanovirin-N.
Botos I; Mori T; Cartner LK; Boyd MR; Wlodawer A
Biochem Biophys Res Commun; 2002 May; 294(1):184-90. PubMed ID: 12054761
[TBL] [Abstract][Full Text] [Related]
3. Flipping the switch from monomeric to dimeric CV-N has little effect on antiviral activity.
Barrientos LG; Lasala F; Delgado R; Sanchez A; Gronenborn AM
Structure; 2004 Oct; 12(10):1799-807. PubMed ID: 15458629
[TBL] [Abstract][Full Text] [Related]
4. Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition.
Barrientos LG; Matei E; Lasala F; Delgado R; Gronenborn AM
Protein Eng Des Sel; 2006 Dec; 19(12):525-35. PubMed ID: 17012344
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of cyanovirin-N, a potent HIV-inactivating protein.
Bewley CA; Gustafson KR; Boyd MR; Covell DG; Bax A; Clore GM; Gronenborn AM
Nat Struct Biol; 1998 Jul; 5(7):571-8. PubMed ID: 9665171
[TBL] [Abstract][Full Text] [Related]
6. Nerve growth factor in different crystal forms displays structural flexibility and reveals zinc binding sites.
Holland DR; Cousens LS; Meng W; Matthews BW
J Mol Biol; 1994 Jun; 239(3):385-400. PubMed ID: 8201620
[TBL] [Abstract][Full Text] [Related]
7. Atomic mapping of the interactions between the antiviral agent cyanovirin-N and oligomannosides by saturation-transfer difference NMR.
Sandström C; Berteau O; Gemma E; Oscarson S; Kenne L; Gronenborn AM
Biochemistry; 2004 Nov; 43(44):13926-31. PubMed ID: 15518540
[TBL] [Abstract][Full Text] [Related]
8. Role of the amino acid sequence in domain swapping of the B1 domain of protein G.
Sirota FL; Héry-Huynh S; Maurer-Stroh S; Wodak SJ
Proteins; 2008 Jul; 72(1):88-104. PubMed ID: 18186476
[TBL] [Abstract][Full Text] [Related]
9. Analysis of sequence requirements for biological activity of cyanovirin-N, a potent HIV (human immunodeficiency virus)-inactivating protein.
Mori T; Shoemaker RH; Gulakowski RJ; Krepps BL; McMahon JB; Gustafson KR; Pannell LK; Boyd MR
Biochem Biophys Res Commun; 1997 Sep; 238(1):218-22. PubMed ID: 9299482
[TBL] [Abstract][Full Text] [Related]
10. A Designed "Nested" Dimer of Cyanovirin-N Increases Antiviral Activity.
Woodrum BW; Maxwell J; Allen DM; Wilson J; Krumpe LR; Bobkov AA; Hill RB; Kibler KV; O'Keefe BR; Ghirlanda G
Viruses; 2016 Jun; 8(6):. PubMed ID: 27275831
[TBL] [Abstract][Full Text] [Related]
11. Overcoming residual frustration in domain-swapping: the roles of disulfide bonds in dimerization and aggregation.
Cho SS; Levy Y; Onuchic JN; Wolynes PG
Phys Biol; 2005 Jun; 2(2):S44-55. PubMed ID: 16204848
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of a double mutant of the carboxy-terminal dimerization domain of the HIV-1 capsid protein.
Wong HC; Shin R; Krishna NR
Biochemistry; 2008 Feb; 47(8):2289-97. PubMed ID: 18220423
[TBL] [Abstract][Full Text] [Related]
13. Domain swapping in N-truncated human cystatin C.
Janowski R; Abrahamson M; Grubb A; Jaskolski M
J Mol Biol; 2004 Jul; 341(1):151-60. PubMed ID: 15312769
[TBL] [Abstract][Full Text] [Related]
14. Properties of cyanovirin-N (CV-N): inactivation of HIV-1 by sessile cyanovirin-N (sCV-N).
Gandhi MJ; Boyd MR; Yi L; Yang GG; Vyas GN
Dev Biol (Basel); 2000; 102():141-8. PubMed ID: 10794101
[TBL] [Abstract][Full Text] [Related]
15. X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)--an initial glance of the viral DNA binding platform.
Chen Z; Yan Y; Munshi S; Li Y; Zugay-Murphy J; Xu B; Witmer M; Felock P; Wolfe A; Sardana V; Emini EA; Hazuda D; Kuo LC
J Mol Biol; 2000 Feb; 296(2):521-33. PubMed ID: 10669606
[TBL] [Abstract][Full Text] [Related]
16. Topological determinants of protein domain swapping.
Ding F; Prutzman KC; Campbell SL; Dokholyan NV
Structure; 2006 Jan; 14(1):5-14. PubMed ID: 16407060
[TBL] [Abstract][Full Text] [Related]
17. Orienting domains in proteins using dipolar couplings measured by liquid-state NMR: differences in solution and crystal forms of maltodextrin binding protein loaded with beta-cyclodextrin.
Skrynnikov NR; Goto NK; Yang D; Choy WY; Tolman JR; Mueller GA; Kay LE
J Mol Biol; 2000 Feb; 295(5):1265-73. PubMed ID: 10653702
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a stable dimeric mutant of cyanovirin-N (CV-N) from a T7 phage-displayed CV-N mutant library.
Han Z; Xiong C; Mori T; Boyd MR
Biochem Biophys Res Commun; 2002 Apr; 292(4):1036-43. PubMed ID: 11944919
[TBL] [Abstract][Full Text] [Related]
19. Combined results from solution studies on intact influenza virus M1 protein and from a new crystal form of its N-terminal domain show that M1 is an elongated monomer.
Arzt S; Baudin F; Barge A; Timmins P; Burmeister WP; Ruigrok RW
Virology; 2001 Jan; 279(2):439-46. PubMed ID: 11162800
[TBL] [Abstract][Full Text] [Related]
20. Structures and solution properties of two novel periplasmic sensor domains with c-type heme from chemotaxis proteins of Geobacter sulfurreducens: implications for signal transduction.
Pokkuluri PR; Pessanha M; Londer YY; Wood SJ; Duke NE; Wilton R; Catarino T; Salgueiro CA; Schiffer M
J Mol Biol; 2008 Apr; 377(5):1498-517. PubMed ID: 18329666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
